CTRI/2022/05/042905尚未招募未知
inear Clinical Study to Evaluate the Anti-Inflammatory and Beneficial Effects ofβ-1, 3-1, 6-Glucan, N-163 on DMD Patients - N-163
MediNippon Health Care Private Limited MD0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Subject who diagnosed with DMD
- •2. Male subject of age in between 3 years to 30 years
- •3. Subjects and legally authorized representative for vulnerable subjects must be willing to participate in the study and provide a written informed consent
- •4. Subject willing to and able to comply with the protocol
排除标准
- •1. Subject participated in another clinical trial in the last 30 days.
- •2. Subjects and legally authorized representative for vulnerable subjects who has not given informed consent for this study
研究者
相似试验
已完成
不适用
Clinical study to evaluate the efficacy, pharmacokinetics and safety of immunoglobulin intravenous (human) 10% (NewGam) in patients with primary immunodeficiency diseasesCommon variable immunodeficiencyPrimary immunodeficiency diseases (PID)Haematological DisordersISRCTN05425999Octapharma AG (Switzerland)50
尚未招募
3 期
Effect of Ayurvedic Eye Treatment in Diabetic RetinopathyCTRI/2022/10/046903ational Institute of Ayurveda Jaipur
进行中（未招募）
3 期
Clinical study to assess how well wilate works in the regular treatment of young children with severe von Willebrand diseaseISRCTN11217735Octapharma (Austria)12
招募中
不适用
Clinical pharmacology study to evaluate the pharmacokinetics, safety and efficacy of multi-targetted tyrosine kinase inhibitor regorafenib in Japanese patients with advanced colorectal cancer.Colorectal CancerJPRN-UMIN000013939Showa University School of Medicine100
招募中
不适用
Clinical pharmacy services to improve management outcomes of Chronic Kidney Disease of uncertain etiology patients undergoing hemodialysisChronic Kidney Disease of uncertain etiologySLCTR/2018/011ational Science Foundation